Show simple item record

dc.contributor.authorSnell, KIEen_US
dc.contributor.authorWard, DGen_US
dc.contributor.authorGordon, NSen_US
dc.contributor.authorGoldsmith, JCen_US
dc.contributor.authorSutton, AJen_US
dc.contributor.authorPatel, Pen_US
dc.contributor.authorJames, NDen_US
dc.contributor.authorZeegers, MPen_US
dc.contributor.authorCheng, KKen_US
dc.contributor.authorBryan, RTen_US
dc.date.accessioned2020-04-01T10:29:49Z
dc.date.issued2018-05-18en_US
dc.identifier.citationOncotarget, 2018, 9 (38), pp. 25244 - 25253en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3564
dc.identifier.eissn1949-2553en_US
dc.identifier.doi10.18632/oncotarget.25397en_US
dc.format.extent25244 - 25253en_US
dc.languageenen_US
dc.language.isoenen_US
dc.publisherImpact Journals, LLCen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.titleExploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratificationen_US
dc.typeJournal Article
rioxxterms.versionofrecord10.18632/oncotarget.25397en_US
rioxxterms.licenseref.startdate2018-05-18en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfOncotargeten_US
pubs.issue38en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Prostate and Bladder Cancer Research
pubs.publication-statusPublisheden_US
pubs.volume9en_US
pubs.embargo.termsNot knownen_US
icr.researchteamProstate and Bladder Cancer Researchen_US
dc.contributor.icrauthorJames, Nicholasen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/